Table 1.
Baseline clinical characteristics of the participants.
| Characteristics | n | % |
|---|---|---|
| Males | 111 | 77.6 |
| Schizophrenia | 103 | 72.7 |
| Schizo-affective disorder | 40 | 27.3 |
| Mean | SD | |
| Age (years) | 31.4 | 8.2 |
| Educational level (years) | 12.6 | 2.4 |
| Premorbid IQ | 104 | 8 |
| Age at onset of illness (years) | 21.4 | 5.6 |
| Duration of untreated psychosis (years) | 1.5 | 3 |
| Total duration of hospitalization (months) | 5.9 | 7.2 |
| PANSS total score | 57.6 | 18.9 |
| Antipsychotics in chlorpromazine equivalents (mg/24 h) | 460.7 | 386.4 |
| CGI severity | 4.1 | 1.4 |
| PSP | 52.6 | 17.5 |
| S-QoL | 50.1 | 19.8 |
PANSS positive and negative syndrome scale, CGI severity clinical global impression-severity scale, PSP personal and social performance scale, S-QoL schizophrenia quality of life questionnaire.